No one found the company yet that I mentioned had
Post# of 1418
(Total Views: 310)
Posted On: 03/25/2022 4:22:58 PM
No one found the company yet that I mentioned had almost 1/2 billion market cap?
Certainly stock bashers wouldn't find it because they get all their information information and investment advice off of a message board.
Pardes Biosciences market cap was $464M when I was looking at it, but down a bit today and sits at $450M
Has just one thing in phase 1 trials which is a Protease Inhibitor.
Todos should be over 1/2B at least compared to Pardes Biosciences from what I can see, but do your own DD.
Pardes Biosciences has 0 revenues. Zip, nada, nothing
They presented at the International Conference On Antiviral Research yesterday
But wait, there is more...
The also just hired a new CEO this month. Get this...
$625,000 and is eligible to receive an annual bonus with a target payout initially equal to fifty percent (50%) of his base salary! That's almost $1M smackers not even including stock.
Mr. Wiggans also was granted (i) an incentive stock option to purchase 60,000 shares of the Company’s common stock and (ii) a non-qualified stock option to purchase 925,000 shares of the Company’s common stock
That's a LOT of compensation. Seems odd people crying over what Gerald makes. What if 3CL hired Mr. Wiggans and had to pay out all that loot?
But wait, there is even more if you can believe that...
Pardes Biosciences went public only last Summer
Guess who backed them?
Gilead and Foresite, Yup the same Gilead as in remdesivir
Pardes went public via SPAC with a blank check company.
This was in the November 30, 2021 binding agreement with NCL Pharma
"Todos shall also commit its efforts toward facilitating a “Go Public” transaction (IPO, SPAC or reverse merger) for 3CL Sciences within 9 months of the Closing, which may also include a buyout of the unowned 40% of 3CL Sciences in shares by Todos upon mutual agreement."
Anyone else starting to see the picture?
What if Pardes Biosciences fails, what will Gilead do?
What if another BP company wants to compete with Gilead? What will they do? Start from scratch?
Hey, if Todos missed the pandemic and boat, why is Gilead sailing behind them and throwing money at it?
Inquiring minds want to know.
I 'can' wait until Todos is valued at 1/2B too, but let's start with revenue next week.
Certainly stock bashers wouldn't find it because they get all their information information and investment advice off of a message board.
Pardes Biosciences market cap was $464M when I was looking at it, but down a bit today and sits at $450M
Has just one thing in phase 1 trials which is a Protease Inhibitor.
Todos should be over 1/2B at least compared to Pardes Biosciences from what I can see, but do your own DD.
Pardes Biosciences has 0 revenues. Zip, nada, nothing
They presented at the International Conference On Antiviral Research yesterday
But wait, there is more...
The also just hired a new CEO this month. Get this...
$625,000 and is eligible to receive an annual bonus with a target payout initially equal to fifty percent (50%) of his base salary! That's almost $1M smackers not even including stock.
Mr. Wiggans also was granted (i) an incentive stock option to purchase 60,000 shares of the Company’s common stock and (ii) a non-qualified stock option to purchase 925,000 shares of the Company’s common stock
That's a LOT of compensation. Seems odd people crying over what Gerald makes. What if 3CL hired Mr. Wiggans and had to pay out all that loot?
But wait, there is even more if you can believe that...
Pardes Biosciences went public only last Summer
Guess who backed them?
Gilead and Foresite, Yup the same Gilead as in remdesivir
Pardes went public via SPAC with a blank check company.
This was in the November 30, 2021 binding agreement with NCL Pharma
"Todos shall also commit its efforts toward facilitating a “Go Public” transaction (IPO, SPAC or reverse merger) for 3CL Sciences within 9 months of the Closing, which may also include a buyout of the unowned 40% of 3CL Sciences in shares by Todos upon mutual agreement."
Anyone else starting to see the picture?
What if Pardes Biosciences fails, what will Gilead do?
What if another BP company wants to compete with Gilead? What will they do? Start from scratch?
Hey, if Todos missed the pandemic and boat, why is Gilead sailing behind them and throwing money at it?
Inquiring minds want to know.
I 'can' wait until Todos is valued at 1/2B too, but let's start with revenue next week.
(2)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼